Cargando…
Meta-Analysis of MS-Based Proteomics Studies Indicates Interferon Regulatory Factor 4 and Nucleobindin1 as Potential Prognostic and Drug Resistance Biomarkers in Diffuse Large B Cell Lymphoma
SIMPLE SUMMARY: Mass spectrometry-based proteomics studies have suggested various proteins as diagnostic, prognostic, and druggable targets in diffuse large B cell lymphoma. Given rather divergent results in previous mass-spectrometry-based studies, we aimed to review these studies to obtain a conse...
Autores principales: | Ejtehadifar, Mostafa, Zahedi, Sara, Gameiro, Paula, Cabeçadas, José, da Silva, Maria Gomes, Beck, Hans C., Carvalho, Ana Sofia, Matthiesen, Rune |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818977/ https://www.ncbi.nlm.nih.gov/pubmed/36611989 http://dx.doi.org/10.3390/cells12010196 |
Ejemplares similares
-
Proteomic Landscape of Extracellular Vesicles for Diffuse Large B-Cell Lymphoma Subtyping
por: Carvalho, Ana Sofia, et al.
Publicado: (2021) -
Assessment of a Large-Scale Unbiased Malignant Pleural Effusion Proteomics Study of a Real-Life Cohort
por: Zahedi, Sara, et al.
Publicado: (2022) -
Extracellular Vesicles in Diffuse Large B Cell Lymphoma: Characterization and Diagnostic Potential
por: Matthiesen, Rune, et al.
Publicado: (2022) -
The Multifaceted Nature of Nucleobindin-2 in Carcinogenesis
por: Skorupska, Anna, et al.
Publicado: (2021) -
New insights into functional regulation in MS-based drug profiling
por: Carvalho, Ana Sofia, et al.
Publicado: (2016)